文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

探索一条充满挑战的道路：使用定制的口服纳米装甲益生菌进行精准疾病治疗。

Navigating a challenging path: precision disease treatment with tailored oral nano-armor-probiotics.

作者信息

Chen Anmei, Gong Ying, Wu Shaoquan, Du Ye, Liu Zhijun, Jiang Yuhong, Li Jiahong, Miao Yang-Bao

机构信息

School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, 610041, China.

Department of Haematology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine of University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu, 610000, China.

出版信息

J Nanobiotechnology. 2025 Feb 1;23(1):72. doi: 10.1186/s12951-025-03141-3.

DOI:10.1186/s12951-025-03141-3
PMID:39893419
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11786591/
Abstract

Oral probiotics have significant potential for preventing and treating many diseases. Yet, their efficacy is often hindered by challenges related to survival and colonization within the gastrointestinal tract. Nanoparticles emerge as a transformative solution, offering robust protection and enhancing the stability and bioavailability of these probiotics. This review explores the innovative application of nanoparticle-armored engineered probiotics for precise disease treatment, specifically addressing the physiological barriers associated with oral administration. A comprehensive evaluation of various nano-armor probiotics and encapsulation methods is provided, carefully analyzing their respective merits and limitations, alongside strategies to enhance probiotic survival and achieve targeted delivery and colonization within the gastrointestinal tract. Furthermore, the review explores the potential clinical applications of nano-armored probiotics in precision therapeutics, critically addressing safety and regulatory considerations, and proposing the innovative concept of 'probiotic intestinal colonization with nano armor' for brain-targeted therapies. Ultimately, this review aspires to guide the advancement of nano-armored probiotic therapies, driving progress in precision medicine and paving the way for groundbreaking treatment modalities.

摘要

口服益生菌在预防和治疗多种疾病方面具有巨大潜力。然而，它们的功效常常受到与在胃肠道内存活和定殖相关挑战的阻碍。纳米颗粒作为一种变革性解决方案出现，为这些益生菌提供强大保护，并提高其稳定性和生物利用度。本综述探讨了纳米颗粒包裹的工程益生菌在精准疾病治疗中的创新应用，特别针对口服给药相关的生理屏障。提供了对各种纳米包裹益生菌和包封方法的全面评估，仔细分析了它们各自的优缺点，以及提高益生菌存活率并在胃肠道内实现靶向递送和定殖的策略。此外，本综述探讨了纳米包裹益生菌在精准治疗中的潜在临床应用，批判性地讨论了安全性和监管方面的考虑因素，并提出了“纳米铠甲益生菌肠道定殖”用于脑靶向治疗的创新概念。最终，本综述旨在指导纳米包裹益生菌疗法的发展，推动精准医学的进步，并为开创性的治疗方式铺平道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/96c874005c13/12951_2025_3141_Fig23_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/92fcc97c1e9a/12951_2025_3141_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/468ca529862b/12951_2025_3141_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/a3642fb05de9/12951_2025_3141_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/9ffcbbdcc21e/12951_2025_3141_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/c12921ae53bc/12951_2025_3141_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/f2fd40d74b9b/12951_2025_3141_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/9d4d8a6afae9/12951_2025_3141_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/9354933d6f3b/12951_2025_3141_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/f5e3e2583c5b/12951_2025_3141_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/cc78800319ce/12951_2025_3141_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/53eb418a53dd/12951_2025_3141_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/045c0270ec70/12951_2025_3141_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/d256efa1958d/12951_2025_3141_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/a7b9662ad5af/12951_2025_3141_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/f26046a44a19/12951_2025_3141_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/443e5c198d0d/12951_2025_3141_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/fcea818c4474/12951_2025_3141_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/07e7e6d7f77e/12951_2025_3141_Fig18_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/7f76afea4023/12951_2025_3141_Fig19_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/7904b215aaaa/12951_2025_3141_Fig20_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/c1067b8545fd/12951_2025_3141_Fig21_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/997a20a712bf/12951_2025_3141_Fig22_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/96c874005c13/12951_2025_3141_Fig23_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/92fcc97c1e9a/12951_2025_3141_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/468ca529862b/12951_2025_3141_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/a3642fb05de9/12951_2025_3141_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/9ffcbbdcc21e/12951_2025_3141_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/c12921ae53bc/12951_2025_3141_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/f2fd40d74b9b/12951_2025_3141_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/9d4d8a6afae9/12951_2025_3141_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/9354933d6f3b/12951_2025_3141_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/f5e3e2583c5b/12951_2025_3141_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/cc78800319ce/12951_2025_3141_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/53eb418a53dd/12951_2025_3141_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/045c0270ec70/12951_2025_3141_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/d256efa1958d/12951_2025_3141_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/a7b9662ad5af/12951_2025_3141_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/f26046a44a19/12951_2025_3141_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/443e5c198d0d/12951_2025_3141_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/fcea818c4474/12951_2025_3141_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/07e7e6d7f77e/12951_2025_3141_Fig18_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/7f76afea4023/12951_2025_3141_Fig19_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/7904b215aaaa/12951_2025_3141_Fig20_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/c1067b8545fd/12951_2025_3141_Fig21_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/997a20a712bf/12951_2025_3141_Fig22_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed0/11786591/96c874005c13/12951_2025_3141_Fig23_HTML.jpg

相似文献

[1]
Navigating a challenging path: precision disease treatment with tailored oral nano-armor-probiotics.

J Nanobiotechnology. 2025-2-1

[2]
Single-cell encapsulation systems for probiotic delivery: Armor probiotics.

Adv Colloid Interface Sci. 2024-10

[3]
Self-Nourishing and Armored Probiotics via Egg-Inspired Encapsulation.

Adv Healthc Mater. 2025-4

[4]
The Gut Microbiome Advances Precision Medicine and Diagnostics for Inflammatory Bowel Diseases.

Int J Mol Sci. 2024-10-19

[5]
Advances in CRISPR-Cas systems for gut microbiome.

Prog Mol Biol Transl Sci. 2024

[6]
Microfluidic Strategies for Encapsulation, Protection, and Controlled Delivery of Probiotics.

J Agric Food Chem. 2024-7-10

[7]
Probiotics Encapsulated via Biological Macromolecule for Neurological Therapy and Functional Food: A Review.

Probiotics Antimicrob Proteins. 2025-6

[8]
Armored probiotics for oral delivery.

Smart Med. 2023-7-20

[9]
Responsively Degradable Nanoarmor-Assisted Super Resistance and Stable Colonization of Probiotics for Enhanced Inflammation-Targeted Delivery.

Adv Mater. 2024-5

[10]
Prebiotics empower probiotics with gastrointestinal stress resistance for colon-targeted release to synergistically alleviate colitis.

J Control Release. 2025-4-10

引用本文的文献

[1]
New advances in oral microbiology and tumor research.

World J Clin Oncol. 2025-7-24

[2]
Modified-Release Pulmonary Delivery Systems for Labile Bioactives: Design, Development, and Applications.

Pharmaceutics. 2025-4-3

[3]
Nanobiotechnology Unveils the Power of Probiotics: A Comprehensive Review on the Synergistic Role of Probiotics and Advanced Nanotechnology in Enhancing Geriatric Health.

Cureus. 2025-3-12

本文引用的文献

[1]
Armored probiotics for oral delivery.

Smart Med. 2023-7-20

[2]
Single-cell encapsulation systems for probiotic delivery: Armor probiotics.

Adv Colloid Interface Sci. 2024-10

[3]
Infectious and Inflammatory Microenvironment Self-Adaptive Artificial Peroxisomes with Synergetic Co-Ru Pair Centers for Programmed Diabetic Ulcer Therapy.

Adv Mater. 2024-9

[4]
Engineered Probiotic Bio-Heterojunction with Robust Antibiofilm Modality via "Eating" Extracellular Polymeric Substances for Wound Regeneration.

Adv Mater. 2024-8

[5]
Nanoformulations in Pharmaceutical and Biomedical Applications: Green Perspectives.

Int J Mol Sci. 2024-5-27

[6]
Probiotics Armed with In Situ Mineralized Nanocatalysts and Targeted Biocoatings for Multipronged Treatment of Inflammatory Bowel Disease.

Nano Lett. 2024-5-24

[7]
Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery.

Biomaterials. 2024-9

[8]
Polyphenolic Nanoparticle-Modified Probiotics for Microenvironment Remodeling and Targeted Therapy of Inflammatory Bowel Disease.

ACS Nano. 2024-5-21

[9]
Transition-Metal-Based Nanozymes: Synthesis, Mechanisms of Therapeutic Action, and Applications in Cancer Treatment.

ACS Nano. 2024-5-14

[10]
Recent progress on engineered micro/nanomaterials mediated modulation of gut microbiota for treating inflammatory bowel disease.

J Control Release. 2024-6

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索